Mansberg Robert, Bency Rosamma, Shen Lily, Bui Chuong, Park Kris
Nepean Hospital, Clinic of PET and Nuclear Medicine, Penrith, Australia. E-mail:
Mol Imaging Radionucl Ther. 2015 Feb 5;24(1):29-31. doi: 10.4274/mirt.98598.
A 39 year old female presented with rapidly enlarging goitre, minimal obstructive symptoms and no constitutional symptoms. Clinical examination revealed diffusely enlarged, firm, non-tender thyroid gland. Biochemical investigations showed subclinical hypothyroidism, positive thyroid antibodies and unremarkable inflammatory markers. Ultrasound examination and CT scan of the neck were suspicious of Riedels thyroiditis. The patient was referred for a FDG PET scan to evaluate for systemic fibro-inflammatory process or lymphoma. Subsequent core biopsy of the thyroid gland demonstrated a chronic inflammatory process with fibrosis consistent with Riedels thyroiditis. A FDG PET/CT study showed diffuse FDG uptake in the thyroid gland and no abnormal retroperitoneal FDG uptake elsewhere to suggest active retroperitoneal fibrosis. The goitre reduced in size with thyroid hormone replacement and steroids, however the patient was lost to follow up.
一名39岁女性因甲状腺肿迅速增大前来就诊,仅有轻微梗阻症状,无全身症状。临床检查发现甲状腺弥漫性肿大、质地硬、无压痛。生化检查显示亚临床甲状腺功能减退、甲状腺抗体阳性且炎症标志物无异常。颈部超声检查和CT扫描怀疑为Riedel甲状腺炎。患者接受了FDG PET扫描以评估是否存在全身性纤维炎症过程或淋巴瘤。随后的甲状腺核心活检显示为慢性炎症过程伴纤维化,符合Riedel甲状腺炎。一项FDG PET/CT研究显示甲状腺内弥漫性FDG摄取,而其他部位未见异常的腹膜后FDG摄取提示活动性腹膜后纤维化。甲状腺激素替代治疗和类固醇治疗后甲状腺肿缩小,但患者失访。